Member News
-
Lithium Ionic drills high-grade 1.69% Li₂O over 9.6m, 1.27% Li₂O over 10m and 1.61% Li₂O over 4.7m at its Bandeira target, Minas Gerais, Brazil
January 24, 2023 (Source) – Lithium Ionic Corp. (TSXV: LTH; OTCQB: LTHCF; FRA: H3N) (“Lithium Ionic” or the…
-
American Rare Earths Appoints Melissa Sanderson as President of North America
20230124-Mel-Sanderson-appointmentDownload
-
Amended: Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement
January 23, 2023 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (USA:VYYRF) (the “Company” or “Voyageur”) announces that, further to its news…
-
Western Uranium & Vanadium Corp. Announces Utah Processing Plant
January 23, 2023 (Source) – Western Uranium & Vanadium Corp. (CSE:WUC) (OTCQX:WSTRF) (“Western” or ”Company”) is pleased to…
-
Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs
January 23, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is…
-
Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement
January 20, 2023 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) is pleased to announce…
-
American Rare Earths on target to define a significant JORC resource at Halleck Creek
20230120-ARR-on-target-for-significant-JORC-resourceDownload
-
Western Uranium & Vanadium Provides Shareholder Updates
January 20, 2023 (Source) – Western Uranium & Vanadium Corp. (CSE:WUC) (OTCQX:WSTRF) (“Western” or ”Company”) is providing the…
-
Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
January 19, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to…
